Biotechnology Empowers Diagnostic Reagents: New Trends in POCT and Precision Medicine
Biotechnology is driving diagnostic reagents toward point-of-care testing, home self-testing, companion diagnostics, and...
Industry Observations on Immune Checkpoint-Related Antibody Reagents and Companion Diagnostic Development
As tumor immunology research and translation continue to deepen, demand for immune checkpoint-related antibodies, recomb...
From Basic Research to Immunotherapy: An Industry Perspective on Cytokine Monitoring
From the tumor immune microenvironment and cytokine release syndrome monitoring to companion diagnostic development, thi...
From Targeted Therapy to Drug Resistance Monitoring: The Clinical Auxiliary Value of Tumor Gene Mutation Testing
This article discusses the auxiliary role of tumor gene mutation testing in molecular subtyping, targeted therapy guidan...
Key Considerations for Selection and Application of Targeted Sequencing Panels in Precision Oncology
Starting from the concept and applications of targeted sequencing panels, this article outlines key considerations for p...
Exploration of Pathology Diagnostic Chips in Precision Medicine and Companion Diagnostics
Precision medicine requires more refined pathological information, and pathology diagnostic chips can provide multi-targ...
Clinical Applications and Interpretation Standards of Immunohistochemistry in Tumor Companion Diagnostics
Immunohistochemistry plays an important role in tumor diagnosis, classification, and companion diagnostics. This article...
Tumor tissue microarrays facilitate drug target validation and companion diagnostic development.
Tumor tissue microarrays enable simultaneous analysis of target expression and molecular characteristics across a large ...
Application of FFPE Tissue Microarrays in Companion Diagnostic Development and Multicenter Studies
Explore the role of FFPE tissue microarrays in companion diagnostic reagent performance evaluation, multicenter consiste...
Application Trends and Selection Recommendations of Tissue Microarrays (TMAs) in Precision Medicine and Biobanking
As precision medicine and biobank development advance, tissue microarrays (TMAs) have attracted increasing attention as ...
Comparative Applications of ADC-Positive Drugs in Companion Diagnostics and Clinical Testing
This article focuses on the critical role of ADC positive drugs as positive controls in companion diagnostics, such as i...
Progress and Compliance Considerations of Tumor Companion Diagnostic Factor Detection Kits in the Field of Liquid Biopsy
Focusing on liquid biopsy technology, this article elaborates on the application progress of tumor companion diagnostic ...